Navigation Links
Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
Date:11/19/2012

trategic Alliance Focused Primarily on Metabolic Diseases.  In August 2012, Regulus entered into a strategic alliance with AstraZeneca AB ("AZ") to discover, develop, and commercialize microRNA therapeutics for three exclusive targets focused on cardiovascular and metabolic diseases and oncology.  AZ made an upfront payment of $3.0 million and purchased $25.0 million of Regulus' common stock in a private placement that closed concurrently with the IPO. In addition, Regulus is eligible to receive preclinical, clinical and commercialization milestone payments of up to $509.0 million, as well as royalties. 
  • Established Research Collaboration to Explore microRNA Biomarkers for Multiple Sclerosis.  In August 2012, Regulus formed a collaboration with Biogen Idec Inc. ("Biogen Idec") to explore microRNA biomarkers for multiple sclerosis.  Regulus received an upfront payment of $750,000 and is eligible to receive milestone payments of up to $1.3 million.  Regulus also received $5.0 million from the sale of a convertible note to Biogen Idec which converted into shares of Regulus' common stock at the closing of the IPO. 
  • Re-Aligned Board of Directors.  In November 2012, Douglas E. Williams, Ph.D., Executive Vice President of Research and Development at Biogen Idec, joined Regulus' Board of Directors.  Concurrently, Stanley T. Crooke, M.D., Ph.D., Chairman of the Board and CEO of Isis Pharmaceuticals, Inc., and Barry E. Greene, President and Chief Operating Officer of Alnylam Pharmaceuticals, Inc., stepped down from the Board and their respective Board committees. 
  • Third Quarter 2012 Financial Results & HighlightsAs of September 30, 2012, Regulus had cash, cash equivalents and short-term investments of $30.9 million compared to $38.1 million at December 31, 2011.  The decrease in cash, cash equivalents and short-term investments was the result of approximately $17.7 m
    '/>"/>

    SOURCE Regulus Therapeutics Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
    2. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
    3. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
    4. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
    5. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
    6. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
    7. Grupo Casa Saba Reports - Grupo Casa Saba Announces its Intention to Delist From the New York Stock Exchange
    8. Solos Endoscopy Reports Book Value of $2,393,522 for Period Ended September 30, 2012
    9. ULURU Inc. Reports Third Quarter 2012 Financial Results
    10. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2012 Results
    11. China Pharma Holdings, Inc. Reports Third Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... LONDON , March 27, 2015 ... commercial prospects for leading ophthalmic drug companies  ... the pharma ophthalmic industry ? Visiongain,s brand new ... trends, opportunities and prospects there. Our 242-page ... most lucrative areas in the industry and the future ...
    (Date:3/27/2015)... 27, 2015   Hospira, Inc. (NYSE: ... and the world,s leading provider of injectable drugs ... an evaluation of biosimilarity of its proposed biosimilar, ... Administration (FDA) conditionally approved name of RETACRIT™, compared ... These study data were presented at the National ...
    (Date:3/27/2015)... BEIJING , March 27, 2015 ... the "Company") (NYSE: CCM ), a leading ... the largest network of radiotherapy and diagnostic imaging ... announced the signing of a purchase agreement under ... wholly owned subsidiary of the Company, agreed to ...
    Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3
    ... announces that a new market research report is ... Drug Discovery in Emerging Markets ... markets have represented important growth opportunities for the ... the extent to which this has been accompanied ...
    ... Calif., Jan. 11, 2011 STAAR Surgical Company (Nasdaq: ... marketer of minimally invasive ophthalmic products, today announced that ... 31, 2010 to exceed $14.2 million. Revenues for the ... over 2009 revenues, driven by an increase of approximately ...
    Cached Medicine Technology:Reportlinker Adds Innovative Drug Discovery in Emerging Markets 2Reportlinker Adds Innovative Drug Discovery in Emerging Markets 3STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 2STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 3STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 4
    (Date:3/28/2015)... Omaha, NE (PRWEB) March 28, 2015 ... leader in healthcare staffing, including physical therapy jobs, ... exhibitor at the Ohio Physical Therapy Association Annual ... the Renaissance Columbus Downtown Hotel in Columbus, OH. ... programming, networking opportunities, and exhibits with products and ...
    (Date:3/28/2015)... (PRWEB) March 28, 2015 Designers and ... new overlay entitled Scratches 5K from Pixel Film Studios. ... effects to any media inside Final Cut Pro X” ... Corporate saves time and is an effective tool for ... FCPX Overlay Scratches 5K's intuitive grunge overlays. Simply drag ...
    (Date:3/28/2015)... 28, 2015 Servpro of Paso ... week released a report about the link between mold ... sufferers, and according to recent medical research, may even ... to the Environmental Protection Agency, people with sensitivity to ... in mold may trigger asthma attacks for asthma sufferers. ...
    (Date:3/27/2015)... 2015 Wellness for Cancer–the first organization ... for the spa and wellness industry–has certified Hands On ... experienced or are living with cancer. Hands On ... Network, will be identified with a special Wellness for ... of safe, therapeutic services for cancer patients. , Wellness ...
    (Date:3/27/2015)... New York (PRWEB) March 27, 2015 ... http://www.lipitorlawsuitcenter.com/ ) that allege the statin medication increases the ... has granted Pfizer Inc.’s Motion to Dismiss four individual ... to a Case Management Order issued in the U.S. ... the Court determined that the dismissals were warranted because ...
    Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3
    ... 7, 2008 CardWorks Servicing, LLC,("CardWorks") the largest ... Cardholder Management Services, LLC ("CMS"), announced,today that the ... HumanaAdvance,Visa Card. CardWorks will partner with E-Duction, Inc., ... HumanaAdvance Visa. Humana,is one of the nation,s largest ...
    ... shows proteins from the reptiles can fight off ,superbugs, , , ... of gator aid. New research suggests that alligator blood could ... by ulcers, burns and even drug-resistant "superbugs." , The research ... have only been tested in the laboratory -- and there,s ...
    ... - Roundtable to examine the crisis in science education, scientific research, ... ... Election -, NEW YORK, April 7, 2008 ... explored some of the most complex,science and human health issues facing the ...
    ... Edmond Medical Center and,ophthalmologists M. Andrew Hogue, M.D. and ... once again participate in the Mission,Cataract Campaign, a program ... afford to pay., Appointments can be made for ... qualifies for the cataract surgery and is in,financial need ...
    ... 2008 Principals announced today a $3,billion dollar ... with,chemical manufacturer W.R.Grace & Co. and related entities, ... from bankruptcy,with no further obligations for asbestos injury ... the 1970,s., Terms of the agreement will ...
    ... 7, 2008 Schoolchildren,who required surgery as infants ... of having problems with inattention and hyperactivity, and,often ... at risk for,academic and behavior problems, and our ... with ongoing follow-up and neurodevelopmental,screening," said study leader ...
    Cached Medicine News:Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 2Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 3Health News:Gator Blood May Be New Source of Antibiotics 2Health News:Gator Blood May Be New Source of Antibiotics 3Health News:Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science' 2Health News:Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science' 3Health News:Edmond Medical Center to Provide Free Cataract Surgeries 2Health News:$3 Billion Asbestos Deal Reached by W.R.Grace Company to Pay Asbestos Victims 2Health News:For Children With Heart Disease, a Risk of Attention and Behavior Problems 2
    ... a malleable, single-use cryosurgical probe developed to ... probe will ablate cardiac tissue while a ... procedure, such as coronary artery bypass grafting ... repair and as part of the Maze ...
    Steerable catheter that is ideal for mapping unusual anatomy...
    ... Mapping. The LASSO Circular Mapping Catheter from ... capable of circumferentially mapping the myocardial sleeves ... design allows the sequential assessment of PV ... vein isolation. The circular LASSO curve ...
    Standard Deflectable Catheters...
    Medicine Products: